US Broker Ratings

BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating the Healthcare Sector with a Cautious Analyst Outlook

BioLife Solutions, Inc. (NASDAQ: BLFS) stands at the forefront of the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: Unpacking the 48.97% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX) has emerged as a notable player in the healthcare sector, specifically within the biotechnology industry, where it focuses on delivering therapies..

Ocular Therapeutix (OCUL) Stock Analysis: Unlocking a Potential 313% Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a pioneering biopharmaceutical firm in the biotechnology industry, is capturing investor attention with its market potential and innovative solutions in the..

Viridian Therapeutics (VRDN) Stock Analysis: Unveiling a 76.68% Potential Upside in Biotech Innovation

For investors with a keen eye on the biotechnology sector, Viridian Therapeutics, Inc. (NASDAQ: VRDN) presents a compelling opportunity with its robust pipeline and the promise..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 50% Upside Potential Amid Revenue Growth

AdaptHealth Corp. (NASDAQ: AHCO) operates within the Healthcare sector, specifically in the Medical Devices industry, and has been making notable strides with its comprehensive range of..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 157% Upside in Healthcare Investments

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector specializing in diagnostics and research, may just be the hidden gem investors are looking..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 68.95% Potential Upside in Biotech

For investors with a keen eye on the biotechnology sector, MiMedx Group, Inc (NASDAQ: MDXG) emerges as a compelling story, particularly when considering its significant potential..

Wave Life Sciences, Inc. (WVE): Investor Outlook on the Biotech’s 443% Potential Upside

Wave Life Sciences, Inc. (NASDAQ: WVE) is capturing headlines with its staggering potential upside of 443.17%, according to the average target price set by analysts. This..

Phreesia, Inc. (PHR) Stock Analysis: Potential 23.52% Upside with Strong Buy Ratings

Phreesia, Inc. (PHR) is capturing investor attention with its robust potential upside and an impressive array of buy ratings from analysts. As of the latest trading..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Is a 26% Upside Within Reach?

Healthcare Services Group, Inc. (NASDAQ: HCSG) may not be the most talked-about name in the healthcare sector, but for investors keen on uncovering growth potential, this..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 134.62% Potential Upside in the Biotech Arena

Dyne Therapeutics, Inc. (NASDAQ: DYN), a dynamic player in the biotechnology sector, is capturing investor attention with an impressive potential upside of 134.62%. This clinical-stage company,..

Structure Therapeutics Inc. (GPCR) Investor Outlook: A Promising Target with 380.61% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company, is catching the attention of investors with its impressive potential upside of 380.61%. Based in South..

Kestra Medical Technologies (KMTS) Stock Analysis: Navigating Growth with 59.9% Revenue Surge

Kestra Medical Technologies, Ltd. (KMTS), a prominent player in the healthcare sector, is making waves with its advanced wearable medical devices aimed at transforming outcomes for..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Capitalizing on a 17.21% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) operates at the intersection of healthcare and information services, providing consumers in the United States with the tools to compare and..

Integra LifeSciences Holdings C (IART): Investor Outlook Reveals 33.83% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices sector, presents an intriguing opportunity for investors looking to diversify their healthcare portfolios...

agilon health, inc. (AGL) Stock Analysis: A Promising 30% Upside Amidst Healthcare’s Evolving Landscape

In the fast-evolving landscape of healthcare services, agilon health, inc. (NYSE: AGL) emerges as an intriguing player with a unique value proposition. Specializing in healthcare services..

NeoGenomics Inc. (NEO): Investor Outlook with a 33% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is capturing investor attention with its comprehensive cancer-focused..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Bausch Health Companies Inc. (BHC): Analyst Consensus and Investor Outlook Highlight a Promising 18.67% Upside

Bausch Health Companies Inc. (NYSE: BHC) has garnered considerable attention in the healthcare sector, specifically within the drug manufacturing space. With its diverse portfolio spanning gastroenterology,..

Artivion, Inc. (AORT) Stock Analysis: Exploring an 89% Potential Upside in the Healthcare Sector

Artivion, Inc. (NASDAQ: AORT) is making waves in the healthcare sector with its promising growth potential and innovative medical devices. With a market capitalization of $1.09..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds